Moberly SP, Berwick ZC, Kohr M, Svendsen M, Mather KJ, Tune JD: Intracoronary glucagon-like peptide 1 preferentially augments glucose uptake in ischemic myocardium independent of changes in coronary flow
its effects are similar to the actions of glucagon-like peptide-1 (GLP-1) for reducing food intake and lowering blood glucose levels
[DOI] [PMC free article] [PubMed] [Google Scholar] 189.Hsu SC, Chang MH, Chen DS, Hsu HC, Lee CY
The application of transcriptomics, animal models, and spatial analysis techniques has introduced novel strategies for elucidating their mechanisms of action
Most important bioactive compounds secreted by enteroendocrine L cells in the gut due to nutrient uptake are glucagon-like peptides (GLPs) including GLP-1 and GLP-2